28 October 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

The latest on the wire

Announcements from businesses shaping what comes next.

UPDATED THROUGHOUT THE DAY
Business wire2096

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

ZIIHERA plus TEVIMBRA and chemotherapy demonstrated clinically meaningful and statistically significant improvements in PFS and OS versus trastuzumab and chemotherapy ZIIHERA plus chemotherapy showed a clinically meaningful and statistically significant improv